Please assess the completion status of the following clinical trial:

Trial Title: Alteplase for Blood Flow Restoration in Hemodialysis Catheters

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Adults \> 18 yrs old~2. Hemodialysis patients~3. Vascular access with a permanent catheter~4. No prior rt-PA use in the catheter over the previous 21 days~5. One rt-PA instillation per catheter (i.e. we will only document the results of 1 rt-PA instillation per catheter. Numerous rt-PA instillations in the same catheter will NOT be considered new events, and not entered into the study)~Exclusion Criteria:~1. Critically ill patients in the ICU setting.~2. Contraindications / cautions with alteplase use including: known hypersensitivity to alteplase or its components (l-arginine, phosphoric acid, polysorbate 80), patients with known conditions associated with bleeding events (e.g.intracranial bleed in last 4 weeks, major hemorrhage in last 4 weeks (Hgb drop of 20 g/L)), recent surgery (\<48 hours), recent biopsy (\<48 hours), hemostatic defects including severe hepatic disease, or current intracranial / intraspinal neoplasm.~3. Hemodialysis catheter has been in the patient less than 14 days.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Alteplase used by normal dwell procedure
- 2 (Type: EXPERIMENTAL): Alteplase given by an new push protocol

Based on this trial design, predict the completion outcome and termination type (if applicable).